top of page
Search


Ivermectin, the 2026 Midterm Results and the US Cancer Industry: What Changes, What Doesn't, and What Patients Should Know
Did the 2026 midterms change ivermectin or US cancer research? A neutral, sourced explainer: ivermectin's FDA status, the NCI's preclinical study, state over-the-counter laws, where NIH and NCI funding stands, what Congress can and cannot do, myths versus facts, and what cancer patients should do now.

Dr. Ryan Heals, Pharm.D.
Nov 46 min read
Â
Â
Â
bottom of page
